Tim Axtelle

542 total citations
12 papers, 428 citations indexed

About

Tim Axtelle is a scholar working on Epidemiology, Immunology and Pharmacology. According to data from OpenAlex, Tim Axtelle has authored 12 papers receiving a total of 428 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Epidemiology, 8 papers in Immunology and 2 papers in Pharmacology. Recurrent topics in Tim Axtelle's work include Immune Response and Inflammation (8 papers), Sepsis Diagnosis and Treatment (5 papers) and Pneumonia and Respiratory Infections (4 papers). Tim Axtelle is often cited by papers focused on Immune Response and Inflammation (8 papers), Sepsis Diagnosis and Treatment (5 papers) and Pneumonia and Respiratory Infections (4 papers). Tim Axtelle collaborates with scholars based in United States, Netherlands and Vietnam. Tim Axtelle's co-authors include John P. Pribble, Terence Turner, Annelies Verbon, Tom van der Poll, Sander J. H. van Deventer, Sonia Souza, Pascale E. P. Dekkers, C. Erik Hack, T. McDowell and Frans J. Hoek and has published in prestigious journals such as The Journal of Immunology, The Journal of Infectious Diseases and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Tim Axtelle

12 papers receiving 414 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tim Axtelle United States	11	207	141	94	64	39	12	428
Jonathan Cohen United Kingdom	11	227 1.1×	147 1.0×	49 0.5×	48 0.8×	12 0.3×	18	422
G. P. Fiori Italy	13	83 0.4×	154 1.1×	67 0.7×	83 1.3×	36 0.9×	31	455
M. Seidelmann Germany	14	165 0.8×	126 0.9×	93 1.0×	25 0.4×	32 0.8×	20	434
H.‐J. Lv China	12	254 1.2×	71 0.5×	88 0.9×	78 1.2×	64 1.6×	88	564
DD Poutsiaka United States	7	360 1.7×	169 1.2×	124 1.3×	35 0.5×	24 0.6×	10	623
Natasja de Bont Netherlands	11	193 0.9×	106 0.8×	134 1.4×	31 0.5×	55 1.4×	13	460
Charles M. Robertson United States	8	203 1.0×	135 1.0×	148 1.6×	43 0.7×	67 1.7×	9	598
D Pfeil Germany	7	325 1.6×	116 0.8×	181 1.9×	28 0.4×	29 0.7×	14	575
Heitor A. Paula-Neto Brazil	10	324 1.6×	214 1.5×	204 2.2×	72 1.1×	23 0.6×	14	673
Walton J. Montegut United States	9	211 1.0×	99 0.7×	86 0.9×	16 0.3×	17 0.4×	11	383

Countries citing papers authored by Tim Axtelle

Since Specialization

Citations

This map shows the geographic impact of Tim Axtelle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tim Axtelle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tim Axtelle more than expected).

Fields of papers citing papers by Tim Axtelle

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tim Axtelle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tim Axtelle. The network helps show where Tim Axtelle may publish in the future.

Co-authorship network of co-authors of Tim Axtelle

This figure shows the co-authorship network connecting the top 25 collaborators of Tim Axtelle. A scholar is included among the top collaborators of Tim Axtelle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tim Axtelle. Tim Axtelle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

1.

Heald, Alison E., Patrick L. Iversen, Jay Saoud, et al.. (2014). Safety and Pharmacokinetic Profiles of Phosphorodiamidate Morpholino Oligomers with Activity against Ebola Virus and Marburg Virus: Results of Two Single-Ascending-Dose Studies. Antimicrobial Agents and Chemotherapy. 58(11). 6639–6647. 57 indexed citations

2.

Reinhart, Konrad, Thomas Glück, Jack J. M. Ligtenberg, et al.. (2004). CD14 receptor occupancy in severe sepsis: Results of a phase I clinical trial with a recombinant chimeric CD14 monoclonal antibody (IC14)*. Critical Care Medicine. 32(5). 1100–1108. 57 indexed citations

3.

Olszyna, Dariusz P., Annelies Verbon, John P. Pribble, et al.. (2004). Effect of IC14, an anti-CD14 antibody, on plasma and cell-associated chemokines during human endotoxemia.. PubMed. 14(3). 158–62. 10 indexed citations

4.

Axtelle, Tim & John P. Pribble. (2003). An overview of clinical studies in healthy subjects and patients with severe sepsis with IC14, a CD14-specific chimeric monoclonal antibody. Journal of Endotoxin Research. 9(6). 385–389. 13 indexed citations

5.

Axtelle, Tim & John P. Pribble. (2003). An overview of clinical studies in healthy subjects and patients with severe sepsis with IC14, a CD14-specific chimeric monoclonal antibody. Journal of Endotoxin Research. 9(6). 385–389. 15 indexed citations

6.

Spek, C. Arnold, Annelies Verbon, Hella L. Aberson, et al.. (2003). Treatment with an Anti-CD14 Monoclonal Antibody Delays and Inhibits Lipopolysaccharide-Induced Gene Expression in Humans in Vivo. Journal of Clinical Immunology. 23(2). 132–140. 54 indexed citations

7.

Verbon, Annelies, Joost C.M. Meijers, C. Arnold Spek, et al.. (2002). Effects of IC14, an Anti‐CD14 Antibody, on Coagulation and Fibrinolysis during Low‐Grade Endotoxemia in Humans. The Journal of Infectious Diseases. 187(1). 55–61. 35 indexed citations

8.

Reinhart, Konrad, Jack J. M. Ligtenberg, Klaus Tschaikowsky, et al.. (2001). Phase 1 study with recombinant chimeric monoclonal antibody against human CD14 (IC14) in patients with severe sepsis. Critical Care Medicine. 29(12). 3 indexed citations

9.

Verbon, Annelies, Pascale E. P. Dekkers, Tessa ten Hove, et al.. (2001). IC14, an Anti-CD14 Antibody, Inhibits Endotoxin-Mediated Symptoms and Inflammatory Responses in Humans. The Journal of Immunology. 166(5). 3599–3605. 102 indexed citations

10.

Axtelle, Tim & John P. Pribble. (2001). IC14, a CD14 specific monoclonal antibody, is a potential treatment for patients with severe sepsis. Journal of Endotoxin Research. 7(4). 310–314. 18 indexed citations

11.

Axtelle, Tim & John P. Pribble. (2001). IC14, a CD14 specific monoclonal antibody, is a potential treatment for patients with severe sepsis. Journal of Endotoxin Research. 7(4). 310–314. 29 indexed citations

12.

McDowell, T., Tim Axtelle, Mark W. Chapleau, & François M. Abboud. (1989). Prostaglandins in carotid sinus enhance baroreflex in rabbits. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 257(2). R445–R450. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact